Physician profile
Michael Borrero
NPI 1548791569
$2,350.12
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,213 · 2022: $679 · 2023: $304 · 2024: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $1,200.00 | 2021 | |
| Abbvie INC. | $328.76 | 2023-2024 | Alloderm |
| Davol INC. | $222.07 | 2022 | |
| Integra Lifesciences Corporation | $152.58 | 2022 | |
| Baxter Healthcare | $141.29 | 2021-2022 | |
| Innovation Technologies INC | $115.02 | 2022 | |
| Polynovo North America LLC | $113.45 | 2024 | Novosorb Btm |
| Silk Road Medical, INC. | $61.06 | 2022 | |
| Mentor Worldwide LLC | $15.89 | 2024 | Artoura Breast Tissue Expander |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Borrero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.